COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 1008: Articles 10071-10080  | Next

Covariant Fitness Clusters Reveal Structural Evolution of SARS-CoV-2 Polymerase Across the Human Population
Wang, C., Elghobashi-Meinhardt, N., Balch, W. E.
10.1101/2022.01.07.475295 — Posted: 2022-01-07
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues
Nelson, C. E., Namasivayam, S., Foreman, T. W., Kauffman, K. D., Sakai, S., Dorosky, D. E., Lora, N. E., NIAID/DIR Tuberculosis Imaging Program, , Brooks, K., Potter, E. L., Roederer, M., Sher, A., Weiskopf, D., Sette, A., de Wit, E., Hickman, H. D., Brenchley, J. M., Via, L. E., Barber, D. L.
10.1101/2022.01.06.475282 — Posted: 2022-01-07
Infectious disease dynamics and restrictions on social gathering size
Boyer, C. B., Rumpler, E., Kissler, S. M., Lipsitch, M.
10.1101/2022.01.07.21268585 — Posted: 2022-01-07 Discussion: Onsite
Epidemiological waves - types, drivers and modulators in the COVID-19 pandemic
Harvey, J., Chan, B., Srivastava, T., Zarebski, A. E., Dlotko, P., Blaszczyk, P., Parkinson, R. H., White, L. J., Aguas, R., Mahdi, A.
10.1101/2022.01.07.21268513 — Posted: 2022-01-07
COVID-19 vaccine effectiveness among healthcare workers in Portugal: results from a hospital-based cohort study, December 2020 to November 2021
Gaio, V., Silva, A., Amaral, P., Viana, J. F., Leite, P. P., Dias, C. M., Kislaya, I., Nunes, B., Machado, A.
10.1101/2022.01.07.22268889 — Posted: 2022-01-07 Discussion: Onsite
Outcomes of COVID-19 infection in patients with chronic kidney disease on maintenance hemodialysis at a COVID hospital in India
Singh, R., Krishnasamy, S., Meena, J. K., Sirohiya, P., Kumar, B., Ratre, B. K., Vig, S., Pandit, A., Sagiraju, H. K. R., Gupta, R., Bhatnagar, S.
10.1101/2022.01.07.22268915 — Posted: 2022-01-07
Estimation of excess all-cause mortality due to COVID-19 in Thailand
Wilasang, C., Lincharoen, T., Modchang, C., Chadsuthi, S.
10.1101/2022.01.07.22268886 — Posted: 2022-01-07 Discussion: Onsite
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery
Toor, J., Li, X., Jit, M., Trotter, C., Echeverria-Londono, S., Hartner, A.-M., Roth, J., Portnoy, A., Abbas, K., Ferguson, N. M., Gaythorpe, K. A. M.
10.1101/2022.01.07.22268891 — Posted: 2022-01-07
Inpatient COVID-19 Mortality Rates: What are the predictors?
Al-Amin, M., Islam, M. N., Li, K., Sheils, N. E., Buresh, J.
10.1101/2022.01.07.22268906 — Posted: 2022-01-07
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape
Zhao, F., Keating, C., Ozorowski, G., Shaabani, N., Francino-Urdaniz, I. M., Barman, S., Limbo, O., Burns, A., Zhou, P., Ricciardi, M., Woehl, J., Tran, Q., Turner, H. L., Peng, L., Huang, D., Nemazee, D., Andrabi, R., Sok, D., Teijaro, J. R., Whitehead, T. A., Ward, A. B., Burton, D., Jardine, J. G.
10.1101/2022.01.06.475303 — Posted: 2022-01-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).